News for Healthier Living

Supercharging T-Cells Against HIV's Weak Spots: A New HIV Vaccine Study Reveals New Hope--and New Challenges--for Aging Patients

In a milestone clinical trial published in the Journal of Clinical Investigation, researchers with the UNC Institute for Global Health and Infectious Diseases (IGHID) at the UNC School of Medicine have demonstrated that new vaccines can significantly boost T cells targeting the most vulnerable, conserved regions of HIV--areas considered key to effective immune control.

June 15, 2026


June 15 2026

June 14 2026

June 13 2026

June 12 2026

June 11 2026

June 10 2026

June 9 2026

June 8 2026

June 7 2026

June 5 2026

June 4 2026

June 3 2026

June 2 2026

June 1 2026